Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ANGIV will - over the next 2 Weeks and hit - by . In that time frame, ANGIV's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
ANGIV shares rose +100.00% in Friday, January 30, 2026's trading session, rising from a previous close of $15.76 to move at $15.76. The stock demonstrated notable intraday movement (see ANGIV's key stats for a full breakdown), fluctuating between $15.76 and $15.76, a 0 trading range. While recent weeks have seen some volatility, ANGIV has managed to secure a - no change over the past 2 weeks. The upward price movement was accompanied by remained steady trading volume, with approximately 606 shares changing hands, 0 fewer than the previous session. This amounted to $9.55K in total market activity.
Will ANGIV Continue Its Trend?
According to analyst ratings and projections for ANGIV, Angi Inc. Class A Common Stock When Issued shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for ANGIV currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 28 negative trading days within the past 30 sessions. Based on the ANGIV stock forecast, now is not the best time to buy ANGIV stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on ANGIV covering social and institutional perspectives.
ANGIV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ANGIV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 0.00% to 0.00%) suggest the stock is in a strong bearish momentum phase.Insights into ANGIV's shareholder base show how institutional investors are positioning themselves during these momentum shifts

